ANL
Adlai Nortye Ltd. American Depositary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$907.37M
P/E Ratio
—
EPS
$-1.11
Beta
-0.71
52W High
$17.25
52W Low
$0.88
50-Day MA
$10.13
200-Day MA
$4.27
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. The company is headquartered in Grand Cayman, the Cayman Islands.
Fundamentals
| Revenue (TTM) | $5.00M |
| Gross Profit (TTM) | $5.00M |
| EBITDA | $-34.94M |
| Operating Margin | -330.50% |
| Return on Equity | -414.00% |
| Return on Assets | -42.20% |
| Revenue/Share (TTM) | $0.16 |
| Book Value | $-0.21 |
| Price-to-Book | 82.76 |
| Price-to-Sales (TTM) | 181.47 |
| EV/Revenue | 185.91 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 178.10% |
| Shares Outstanding | $58.73M |
| Float | $66.38M |
| % Insiders | 5.66% |
| % Institutions | 6.90% |
Historical Volatility
HV 10-Day
145.23%
HV 20-Day
176.97%
HV 30-Day
152.91%
HV 60-Day
120.38%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($29.67 target)
3
BuyData last updated: 4/30/2026